Caris Molecular Intelligence combines a thorough and accurate analysis of a profile of the patient’s tumour biomarkers with an extensive review of clinical literature. This provides customers with information about the kinds of treatment available in the cases where standard treatment is not suitable.
Every day, employees of Caris Life Sciences help hundreds of patients around the world, providing services for diagnosis, prognosis and theranostics.
Caris Life Sciences believes the best diagnostic methods enable the development of more effective treatments and, ultimately, the best results for patients suffering from cancer and other serious diseases.
Maintaining services at the highest level is possible due to the work of a dedicated team of highly skilled clinical and medical experts who supervise and monitor the process of laboratory studies and the quality of trials, as well as the process of investigating the evidence-based biomarkers.
Caris offers a number of clinically important tests and laboratory trials from its 5,600 square meter laboratory in Phoenix, USA. It is licensed and certified in accordance with the Clinical Laboratories Improvement Act (CLIA), and in accordance with the laws of the State of New York.
Caris Life Sciences® laboratories have the following certificates: